Impact Factor 3.532

Frontiers reaches 6.4 on Journal Impact Factors

General Commentary ARTICLE

Front. Psychiatry, 17 March 2016 | https://doi.org/10.3389/fpsyt.2016.00041

Commentary: Rewriting the Valuation and Salience of Alcohol-Related Stimuli via Memory Reconsolidation

  • Center for the Clinical Trials Network, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA

A commentary on

Rewriting the valuation and salience of alcohol-related stimuli via memory reconsolidation
by Das RK, Lawn W, Kamboj SK. Transl Psychiatry (2015) 5:e645. doi: 10.1038/tp.2015.132

Neuroadaptations of neuronal ensembles in the mesocorticolimbic reward system mediate memory processes, which link drug-seeking experiences to the contexts in which they occur (13). In many individuals with alcohol or drug-related problems, such memory processes imbue drug-related contexts with motivational salience – a resonant incentive motivational attribution attached to drug-predictive cues, which drives addictive behaviors (46). When such memories are recalled, they are thought to return to a volatile state in which they could be altered before undergoing reconsolidation for future use (79). A recent notable study sheds light on a condition by which to block memory reconsolidation and subsequent responsivity to alcohol-related stimuli in individuals with alcohol-related problems (10).

In hazardous drinkers, Das et al. (10) destabilized alcohol-related memory reconsolidation through a procedure which maximized omission prediction error (PE) through explicitly guided expectancy violation during memory retrieval (10). PE involved these drinkers being led to believe that they will be able to drink alcohol through presentation of alcohol conditioned stimuli to reactivate their alcohol-related memories and explicit instructions designed to maximize the expectation of alcohol reward but then were unexpectedly prevented from drinking. Ten minutes later, alcohol-specific cues were paired with disgusting tastes and images in a counter-conditioning procedure designed to rewrite the alcohol-related memory. Hazardous drinkers exhibited reduced attentional bias to and liking of alcohol-related stimuli and a reduced positive expectancy of alcohol 1 week following this PE and counter-conditioning procedure. Interestingly, this memory reactivation-dependent reduction in the motivational salience and valuation of alcohol-related stimuli generalized to novel alcohol cues. Two comparison groups of hazardous drinkers were included – one that did not undergo PE upon alcohol-related memory retrieval and one in which the alcohol-related memory was not retrieved. Neither of these comparison groups exhibited this reduction in motivational salience or valuation of alcohol-related stimuli, relative to neutral stimuli. This study suggests an innovative approach to destabilize retrieval of alcohol-related memories using a PE manipulation paired with counter conditioning. This method could be useful to disrupt or weaken maladaptive alcohol memories in clinical practice if future research shows it to be a selective alcohol memory-rewriting intervention.

Further research should identify the necessary and sufficient parameters for producing durable weakening of alcohol- and drug-related memories by fortifying PE-induced memory destabilization, together with medication-assisted therapy (MAT) and counter conditioning. A fuller insight gleaned from understanding what is required for memory reconsolidation to be blocked in a long-lasting manner should aid development of treatments to disrupt memories associated with substance use disorders (SUDs). First, it would be helpful for research to test how efficacy of PE-based strategies to block memory reconsolidation could be enhanced by pharmacological adjuncts, for example, adrenergic beta-receptor blockers or adrenergic alpha-2 receptor agonists, which prior research suggests could be useful aids to impair memory reconsolidation (11, 12). Second, research is needed to identify the parameters necessary to optimize the efficacy of counter conditioning and to extend the applicability of the Das et al. (10) memory-destabilization approach to treating other SUDs. Further research should also identify how to maximize the generalizability of memory alteration to other drug-predictive contexts, in order to generalize this relearning across various drug-related surroundings.

Individuals with multiple SUDs may require more intense care to augment any beneficial effects of rewriting maladaptive alcohol- or drug-related memories. Thus, precision medicine research also needs to be conducted to establish effectiveness of stepped care, tailored treatment approaches using nuanced clinical decision support (CDS) tools, and shared decision-making approaches to move SUDs patients into more intensive interventions, which attend to their personalized phenotypes that present obstacles to their recovery and overall wellness, their risk concerns, and preferences. Research is also needed on how to optimize shared decision making between patients and providers to tailor personalized medical care to particular problems and risk categories which individual patients report as most distressing to their functioning in daily lives. Thus, ultimately, precision medicine research will also need to assess the effectiveness of patient-centered care approaches utilizing shared decision making to treating substance use problems and co-occurring behavioral health issues, considering individual preferences for treatment options, taking into account: for instance, (a) SUD severity, (b) readiness of patients to change their harmful substance use, (c) underlying reasons for readiness or hesitancy to do so, (d) presence of co-occurring psychiatric and other medical conditions, and (e) how to help patients in instituting a patient-centered treatment plan consistent with their co-occurring conditions, readiness to change, and their preferences/values (13, 14).

Clinical research programs with practice-based research networks serving patient populations with substance use problems can play an important role in this endeavor. Existing health information system infrastructures in practice-based research networks should be leveraged to help accelerate this line of research, which, in turn, could lead to more efficient enrollment of patients into trials, accelerated recruitment of providers to deliver study interventions, and more efficient use of existing health information technologies such as electronic health record systems (EHRs) (13, 14).

Author Contributions

UG, Ph.D., undertook a review of the literature, conceived of this general commentary, and wrote and reviewed all drafts.

Conflict of Interest Statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

The opinions in this paper are those of the author and do not represent the official position of the U.S. government.

Funding

UG is a Health Scientist Administrator, Program Official, at the Center for the Clinical Trials Network, NIDA, which is the funding agency for the National Drug Abuse Treatment Clinical Trials Network. This commentary was supported through Dr. UG’s duties as a Health Scientist Administrator.

References

1. Cruz FC, Babin KR, Leao RM, Goldart EM, Bossert JM, Shaham Y, et al. Role of nucleus accumbens shell neuronal ensembles in context-induced reinstatement of cocaine-seeking. J Neurosci (2014) 34:7437–46. doi:10.1523/JNEUROSCI.0238-14.2014

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Bossert JM, Stern AL, Theberge FR, Cifani C, Koya E, Hope BT, et al. Ventral medial prefrontal cortex neuronal ensembles mediate context-induced relapse to heroin. Nat Neurosci (2011) 14:420–2. doi:10.1038/nn.2758

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Nestler EJ. Cellular basis of memory for addiction. Dialogues Clin Neurosci (2013) 15:431–43.

PubMed Abstract | Google Scholar

4. Bühler M, Vollstädt-Klein S, Kobiella A, Budde H, Reed LJ, Braus DF, et al. Nicotine dependence is characterized by disordered reward processing in a network driving motivation. Biol Psychiatry (2010) 67:745–52. doi:10.1016/j.biopsych.2009.10.029

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci (2011) 12:652–69. doi:10.1038/nrn3119

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Zhang J, Berridge KC, Tindell AJ, Smith KS, Aldridge JW. A neural computational model of incentive salience. PLoS Comput Biol (2009) 5:e1000437. doi:10.1371/journal.pcbi.1000437

CrossRef Full Text | Google Scholar

7. Tronson NC, Taylor JR. Addiction: a drug-induced disorder of memory reconsolidation. Curr Opin Neurobiol (2013) 23:573–80. doi:10.1016/j.conb.2013.01.022

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Reichelt AC, Lee JL. Memory reconsolidation in aversive and appetitive settings. Front Behav Neurosci (2013) 7:118. doi:10.3389/fnbeh.2013.00118

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Exton-McGuinness MT, Lee JL, Reichelt AC. Updating memories – the role of prediction errors in memory reconsolidation. Behav Brain Res (2015) 278:375–84. doi:10.1016/j.bbr.2014.10.011

CrossRef Full Text | Google Scholar

10. Das RK, Lawn W, Kamboj SK. Rewriting the valuation and salience of alcohol-related stimuli via memory reconsolidation. Transl Psychiatry (2015) 5:e645. doi:10.1038/tp.2015.132

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Lonergan M, Saumier D, Tremblay J, Kieffer B, Brown TG, Brunet A. Reactivating addiction-related memories under propranolol to reduce craving: a pilot randomized controlled trial. J Behav Ther Exp Psychiatry (2016) 50:245–9. doi:10.1016/j.jbtep.2015.09.012

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Otis JM, Werner CT, Mueller D. Noradrenergic regulation of fear and drug-associated memory reconsolidation. Neuropsychopharmacology (2015) 40:793–803. doi:10.1038/npp.2014.243

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Ghitza UE. Needed relapse-prevention research on novel framework (ASPIRE model) for substance use disorders treatment. Front Psychiatry (2015) 6:37. doi:10.3389/fpsyt.2015.00037

CrossRef Full Text | Google Scholar

14. Ghitza UE. ASPIRE model for treating cannabis and other substance use disorders: a novel personalized-medicine framework. Front Psychiatry (2014) 5:180. doi:10.3389/fpsyt.2014.00180

CrossRef Full Text | Google Scholar

Keywords: alcohol drinking, memory retrieval, alcohol use disorder, drug use disorder, substance use disorder, addiction, alcohol abuse, drug abuse

Citation: Ghitza UE (2016) Commentary: Rewriting the Valuation and Salience of Alcohol-Related Stimuli via Memory Reconsolidation. Front. Psychiatry 7:41. doi: 10.3389/fpsyt.2016.00041

Received: 02 January 2016; Accepted: 04 March 2016;
Published: 17 March 2016

Edited by:

Marco Diana, University of Sassari, Italy

Reviewed by:

Diana Martinez, Columbia University, USA

Copyright: © 2016 Ghitza. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Udi E. Ghitza, ghitzau@nida.nih.gov